Trends in premature mortality from diabetes mellitus in Costa Rica in the period 2000–2020

References

• Diabetes Atlas. International Diabetes Federation [accessed 2022 May 9] Available from: https://diabetesatlas.org
   Google Scholar
• Diabetes Mellitus. World Health Organization accessed 10 Nov 2021]. Available at 2021 Nov 10: https://www.who.int/news-room/fact-sheets/detail/diabetes.
   Google Scholar
• Vigilancia de los factores de riesgo cardiovascular, segunda encuesta 2014 Accessed 22 may 2022. Caja Costarricense del Seguro Social[Surveillance of cardiovascular risk factors, second survey 2014. Costa Rica Social Security Box .https://repositorio.binasss.sa.cr/repositorio/bitstream/handle/20.500.11764/628/encuesta2014.pdf?sequence=1&isAllowed=y
   Google Scholar
• Vigilancia de los factores de riesgo cardiovascular, segunda encuesta 2018 Accessed 16 jun 2022. Caja Costarricense del Seguro Social [Surveillance of cardiovascular risk factors, second survey 2018. Costa Rica sSocial Security Box. https://www.binasss.sa.cr/informeservicios2019.pdf
   Google Scholar
• Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020 Sep 8;10(1):14790. PMID: 32901098; PMCID: PMC7478957.
   PubMed Web of Science ®Google Scholar
• Mackenbach JP, Kulhánová I, Menvielle G, et al. Eurothine and EURO-GBD-SE consortiums. Trends in inequalities in premature mortality: a study of 3.2 million deaths in 13 European countries. J Epidemiol Community Health. 2015 Mar;69(3):207–217
   PubMed Web of Science ®Google Scholar
• Regidor E, Santos JM, Ortega P, et al. Decreasing income inequality and emergence of the association between income and premature mortality: Spain, 1970-2010. Health Place. 2014May; 27: 30–37 Epub 2014 Feb 13. PMID: 24530650
   PubMed Web of Science ®Google Scholar
• Holland WW. European Community atlas of avoidable death. 2nd ed. Oxford: Oxford University Press; 1991.
   Google Scholar
• Avoidable mortality: OECD/Eurostat lists of preventable and treatable causes of death, 2022 [accessed 2022 May 9]. Available at: https://www.oecd.org/health/health-systems/Avoidable-mortality-2019-Joint-OECD-Eurostat-List-preventable-treatable-causes-of-death.pdf
   Google Scholar
• Jiménez-Montero JG, Villegas-Barakat M. Changes in DM mortality rate in Costa Rica 2007-2017. DM Res Clin Pract. 2021 Apr;174:108749
   PubMed Web of Science ®Google Scholar
• Estimaciones y proyecciones de población por sexo y edad 1950-2050. defunciones. instituto nacional de estadística y censos [population estimates and projections by sex and age 1950-2050. Deaths. National Institute of Statistics and Censuses] [accessed 2022 May 9]. Available at: https://www.inec.cr/poblacion/defunciones
   Google Scholar
• Gómez-Martínez L, Orozco-Beltrán D, Quesada JA, et al. Trends in premature mortality due to heart failure by autonomous community in Spain: 1999 to 2013. Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):531–537.
   PubMed Web of Science ®Google Scholar
• Ahmad O, Boschi-Pinto C, Lopez A, et al. Age standardization of rates: a new who standard. GPE Discussion Paper Series: No. 31 EIP/GPE/EBD World Health Organization 2001 [accessed 2022 May 9] Available at: https://qmplus.qmul.ac.uk/pluginfile.php/154532/mod_book/chapter/3129/Age%20standardization%20of%20rates.pdf
   Google Scholar
• Indicadores de salud. Aspectos conceptuales y operativos Organización Panamericana de la Salud [Health indicators. Conceptual and operational aspects Pan American Health Organization] [accessed 2022 May 9]. Available at: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=14405:health-indicators-conceptual-and-operational-considerations&Itemid=0&lang=es
   Google Scholar
• IBM Corp. IBM SPSS Statistics for Windows [Internet]. Armonk NY: IBM Corp; 2017 Accessed 10 jun 2022. Available from: https://hadoop.apache.org.
   Google Scholar
• R Core Team. R: a Language and Environment for Statistical Computing [Internet]. Vienna Austria; 2016 Accesed 14 feb 2022. Available from: https://www.R-project.org
   Google Scholar
• Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000Feb15;19(3):335–351. Erratum in: Stat Med 2001 Feb 28;20(4):655. PMID: 10649300.
   PubMed Web of Science ®Google Scholar
• Joinpoint Regression Program, Version 4.9.1.0. Statistical Methodology and Applications Branch. United States: Surveillance Research Program National Cancer Institute; 2022.
   Google Scholar
• Cubero-Alpízar C, P R-VL. Comportamiento de la diabetes mellitus en Costa Rica[Behavior of diabetes mellitus in Costa Rica] Horizonte Sanitario . Horizonte Sanitario. 2017;16(3). 10.19136/hs.a16n3.1871.
   Google Scholar
• Informe de resultados de la Evaluacion de la prestación de Servicios de Salud 2019 Accessed 4 apr 2022. Monitoreo 2020. Caja Costarricense de Seguro Social. Direccion de Servicios de Salud San Jose. https://www.binasss.sa.cr/informeservicios2019.pdf
   Google Scholar
• Schiller M, Solger K, Leipold S, et al. DM-associated nephropathy and obesity influence COVID-19 outcome in type 2 DM patients. J Community Hosp Intern Med Perspect. 2021 Sep 20;11(5):590–596. PMID: 34567446; PMCID: PMC8462845.
   PubMed Web of Science ®Google Scholar
• Gómez Salas G, Quesada Quesada D, Monge Rojas R Perfil antropométrico y prevalencia de sobrepeso y obesidad en la población Urbana de Costa Rica entre los 20 y 65 años agrupados por sexo: resultados del Estudio Latino Americano de Nutrición y Salud [Anthropometric profile and prevalence of overweight and obesity in the urban population of Costa Rica between 20 and 65 years of age, grouped by sex: results of the Latin American Study of Nutrition and Health]. Nutr Hosp. [Internet]. 2020 Jun cited 2022 Apr 16;37(3): 534–542. Available at: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112020000400017&lng=es. Epub -2020 Nov 30
   Google Scholar
• Pabón CA, Hubley E, Spurrell G, et al. Obesidad: análisis de la prevalencia de obesidad y sobrepeso en una población de adultos con bajos ingresos en Costa Rica [Obesity: analysis of the prevalence of obesity and overweight in a population of low-income adults in Costa Rica. Science and Health Magazine Integrating Knowledge. 2021;5(2):46–62.
   Google Scholar
• World Obesity Atlas 2022, World Obesity Federation (London) [accessed 2022 May 9] Available at: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2022
   Google Scholar
• Perales-Torres AL, Castillo-Ruíz O, Castañeda Licón MT, et al. La DM y la alimentación determinantes en la progresión de aterosclerosis [DM and type of diet as determinant factor in the progression of atherosclerosis]. Arch Cardiol Mex. 2016 Oct-Dec;864:326–334.
   PubMedGoogle Scholar
• Lopez Stewart G, Tambascia M, Rosas Guzmán J, et al. Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America. Rev Panam Salud Pública. 2007Jul;22(1):12–20. PMID: 17931483.
   PubMed Web of Science ®Google Scholar
• Brenes-Camacho G, Rosero-Bixby L. Metabolic control in a nationally representative diabetic elderly sample in Costa Rica: patients at community health centers vs. patients at other health care settings. BMC Int Health Hum Rights. 2008 May 14;8:5. PMID: 18447930; PMCID: PMC2396151.
   PubMedGoogle Scholar
• Chen-Ku CH, Gonzalez-Galvez G, Vásquez M, et al. Vascular complications in patients with type 2 DM: prevalence and comorbidities in 6 countries of Latin America. (A cohort of the discover study program). Endocr Pract. 2019Oct;2510:994–1002. Epub 2019 Jun 6. PMID: 31170372
   PubMed Web of Science ®Google Scholar
• Carrillo-Larco RM, Barengo NC, Albitres-Flores L, et al. The risk of mortality among people with type 2 DM in Latin America: a systematic review and meta-analysis of population-based cohort studies. DM Metab Res Rev. 2019 May;35(4):e3139
   PubMed Web of Science ®Google Scholar
• Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American association of clinical endocrinologist and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm- 2020 executive summary. Endocr Pract. 2020Jan;261:107–139. PMID: 32022600
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(1):S98–S110.
   PubMed Web of Science ®Google Scholar
• See S, Care DS, S S. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes―2020. Diabetes Care. (2020). 9;43(June):S98–S110.
   PubMedGoogle Scholar
• Morales-Olvera D, Obregón-Aguilar A, Pérez-Mendoza MT, et al. iSGLT2 y su potencial efecto nefroprotector en pacientes con diabetes mellitus 2 [iSGLT2 and its potential nephroprotective effect in patients with diabetes mellitus 2]. Med Interna Méx. 2022;33(4):503–510.
   Google Scholar
• Chen-Ku CH, Grimaldo de sucre P, Vinocour M, et al. diabetes second-line medication prescription patterns in costa rica and panama: evidence from the discover registry. Cureus. 2021 Jun 30;13(6):e16060. PMID: 34354876; PMCID: PMC8328805.
   PubMed Web of Science ®Google Scholar
• Arellano-Moya DA, Quirós Torres M. Novedades farmacológicas disponibles en Costa Rica para el manejo terapéutico de la DM Mellitus tipo 2 [Pharmacological novelties available in Costa Rica for the therapeutic management of DM Mellitus type 2. Acta Académica, 67 (November), 107–144
   Google Scholar
• Global Health Expenditure Database 2020. World Health Organization [accessed 2021 Nov 10. Available at: https://apps.who.int/nha/database
   Google Scholar
• Death rate, crude (per 1,000 people) - Costa Rica World Bank Development Indicators. [accessed 2022 May 5]. Available at: https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=CR
   Google Scholar
• Wu ZH, Tang Y, Cheng Q. Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol. 2021Feb;58(2):139–144. Epub 2020 Jun 24. PMID: 32583078; PMCID: PMC7311595.
   PubMed Web of Science ®Google Scholar
• Schiller M, Solger K, Leipold S, et al. DM-associated nephropathy and obesity influence COVID-19 outcome in type 2 DM patients. J Community Hosp Intern Med Perspect. 2021 Sep 20;11(5):590–596. PMID: 34567446; PMCID: PMC8462845.
   PubMed Web of Science ®Google Scholar
• Calixto-Calderón B, Vázquez-González MF, Martínez-Peláez R, et al. Pre-existing comorbidity, the highest risk factor for poor prognosis of COVID-19 among the Mexican population. Nova scientia. 2022;13(1).
   Google Scholar
• Tamura RE, Said SM, de Freitas Lm, et al. Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies. Diabetol Metab Syndr. 2021 Jul 13;13(1):76. PMID: 34256824; PMCID: PMC8275913.
   PubMed Web of Science ®Google Scholar
• Sen S, Chakraborty R, Kalita P, et al. DM mellitus and COVID-19: understanding the association in light of current evidence. World J Clin Cases. 2021;9(28):8327–8339.
   PubMed Web of Science ®Google Scholar
• Orozco-Beltrán D, Merino-Torres JF, Pérez A, et al. Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care—APHOSDIAB—COVID-19 Multicenter Study. J Clin Med. 2022;11(8):2092.
   PubMed Web of Science ®Google Scholar
• Shrestha DB, Budhathoki P, Raut S, et al. Diabetes de nueva aparición en COVID-19 y resultados clínicos: una revisión sistemática y metanálisis. Mundo J Virol. 2021;10(5): 275–287
   Google Scholar
• Samper M, González H, “Caracterización de los espacios rurales en Costa Rica y propuestas de alternativas metodológicas para su medición”[“Characterization of rural spaces in Costa Rica and proposals for methodological alternatives for their measurement”Documentos de Proyectos (LC/TS.2020/131; LC/MEX/TS.2020/33), Ciudad de México, Comisión Económica para América Latina y el Caribe (CEPAL), 2020.
   Google Scholar
• Barrantes-Arroyo A, Cortés-Ruiz A, Molina-Granados JM, et al. Afectación de los servicios de atención primaria en salud por la pandemia de COVID-19 en Costa Rica: el recuento de las interrupciones. Gestión En Salud Y Seguridad Social [Affectation of primary health care services by the COVID-19 pandemic in Costa Rica: the count of interruptions. Management in Health and Social Security,1(2), 14–24.
   Google Scholar
• Laclé-Murray A. Causes of death in a diabetic population of costa rica and the quality of their death certificates. Acta méd costarric 2022 Apr 17; 54(1): 23–30.
   Google Scholar